Are serum tumor markers CEA , CYFRA21-1 , and CA-125 associated with worse prognosis in advanced non-small-cell lung cancer ( NSCLC )?
In our analysis, high levels of tumor markers at baseline are correlated with worse survival in stage III-IV NSCLC patients.
This study demonstrated that the circulating sRAGE level was inversely associated with VCS in HD patients independent of the S100A12 level and the severity of systemic inflammation.